Epsilon M&A Deal Report - Branded Pharmaceutical Business of Merckle
Transaction Multiples for the Valuation of Private Companies
Recordati / Branded Pharmaceutical Business of Merckle
No EMAT :
16370
Announced Date :
17/01/2005
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Recordati
Target :
Branded Pharmaceutical Business of Merckle
Country :
Germany
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Branded pharmaceutical business of Merckle GmbH, founded in 1881 with operations headquartered in Ulm, Baden-Württemberg > Manufactures pharmaceuticals. Main products: Claversal® (mesalazine),...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 11/04/2005 | Kalina Concern | Dr Scheller Cosmetics | Germany | ** | 16368 |
| 12/04/2005 | Private Group Led By Management | Home Help Division of Medidep | France | * | 16367 |
Source: Epsilon Research / EMAT
